関連する実験動画
Updated: Jul 10, 2026

07:42
Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
エタノラミン・アンモニア・ライアゼの自殺不活性化の異なるメカニズム
Gregory M Sandala1, David M Smith, Leo Radom
1School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia.
Journal of the American Chemical Society
|June 16, 2005
まとめ
サブストラットアナログは,酵素機能を停止することによって,エタノアミンアンモニアライアゼ (EAL) を阻害することができます. 計算による研究は,安定したラジカルと内熱的なステップを含む明確な無活性化メカニズムを明らかにし,特にグリコアルデヒドと2-ヒドロキシエチルヒドラジンの場合.
科学分野:
- バイオケミストリー バイオケミストリー
- コンピューティング・ケミストリー
- 酵素学 酵素学とは
背景:
- エタノラミンアンモニア・リアーゼ (EAL) は,代謝経路における重要な酵素です.
- 酵素不活性化メカニズムを理解することは,薬物開発とバイオカタリシスにとって不可欠です.
- サブストラットアナログは,酵素機構を調査し,潜在的な阻害物質を特定するためにしばしば使用されます.
研究 の 目的:
- 3つの異なる基板アナログを使用して,EALの自殺不活性化メカニズムを調査する.
- 提案された不活性化経路の計算エネルギーを解明する.
- グリコールアルデヒド,2-ヒドロキシエチルヒドラジン (HEH) と2 - アミノアセタルデヒドの不活性化メカニズムを比較する.
主な方法:
- Ab initio分子軌道計算は,反応経路を研究するために使用されました.
- 移行状態と中間物質の分析により,反応エネルギー学を決定する.
- 計算されたエネルギーと実験観察の比較.
主要な成果:
- 2-アミノエタノールによる正常な触媒機構は,エクソテルミックであると予測されています.
- グリコアルデヒドとHEHは,高度に安定したラジカルとエンドサーミックな水素再抽象のステップを含む経路を通じて無活性化を誘導します.
- 2-アミノアセタルデヒドは異なる不活性化メカニズムを示し,アセチ酸とアンモニアムカチオン形成につながる経路で,ラジカルコファクターを再生します.
結論:
- サブストラットアナログによるEALの自殺不活性化は,異なるメカニズムによって起こります.
- 安定したラジカルとエンドサーミックステップは,グリコアルデヒドとHEHによる無活性化の重要な特徴です.
- 2-アミノアセタルデヒドの不活性化メカニズムは,コファクターの再生を含むが,その後の分解経路はまだ完全に解明されていない.
関連する概念動画
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:

